Related Experiment Videos
Translocation (5;22) in an Askin's tumor
H Christiansen1, M Altmannsberger, F Lampert
1Department of Pediatrics, Justus-Liebig-Universität, Giessen, FRG.
Cancer Genetics and Cytogenetics
|September 1, 1992
Summary
Cytogenetic studies on a boy with Askin's tumor brain metastasis revealed specific chromosomal abnormalities. The investigation identified a derivative chromosome involving chromosomes 5 and 22, with no involvement of chromosome 11.
Area of Science:
- Pediatric Oncology
- Cytogenetics
- Cancer Biology
Background:
- Askin's tumor is a rare malignant neoplasm primarily affecting children and young adults.
- Brain metastases represent a significant challenge in the management of Askin's tumor, impacting prognosis.
- Understanding the genetic underpinnings of tumor progression is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the cytogenetic profile of a brain metastasis from an Askin's tumor.
- To identify specific chromosomal aberrations associated with this metastatic presentation.
- To contribute to the understanding of the molecular basis of Askin's tumor metastasis.
Main Methods:
- Cytogenetic analysis was performed on tumor cells obtained from the brain metastasis.
- Karyotyping was utilized to assess the chromosomal constitution of the tumor cells.
- Detailed analysis of chromosome structure and number was conducted.
Main Results:
- The cytogenetic study revealed a near-diploid karyotype.
- Specific abnormalities included monosomies for chromosomes 5 and 22.
- A derivative chromosome, der(5)t(5;22)(q35;q11), was identified, indicating a translocation between chromosomes 5 and 22.
- Importantly, chromosome 11 showed no involvement in these aberrations.
Conclusions:
- The identified chromosomal abnormalities, particularly der(5)t(5;22)(q35;q11), may play a role in the development or progression of Askin's tumor brain metastasis.
- The absence of chromosome 11 involvement provides specific genetic information for this case.
- Further research is warranted to elucidate the functional significance of these genetic alterations in Askin's tumor.